In days, domestic drugmakers are set to launch cheaper versions of semaglutide, the GLP-1 (glucagon-like peptide-1) therapy popular globally for weight management, following the drugs patent expiry in the country on Friday, 20 March
Regular check-ins with your healthcare provider are crucial
According to a recently published WHO report[8], its prevalence is growing, with it estimated to affect up to 17.5% of the adult population worldwide, including both women and men
Mikki considers this therapy for adults over 30 experiencing age-related decline in energy, sleep, or body composition, athletes and active individuals seeking enhanced recovery and performance, patients interested in proactive anti-aging strategies, those looking to optimize growth hormone naturally without synthetic HGH, and anyone seeking comprehensive wellness optimization
Under normoglycemic conditions, adult cells express low levels of PC1/3 and produce little GLP-1 (16)
To prevent future mistakes, consider watching instructional videos from your pharmacy, marking a small circle on your skin before injection to identify the subcutaneous tissue pocket, or asking a partner or family member to supervise your injection technique